Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam Salek

Showing results (1-10 of 141) with videos related to

Pageof 15
Sort By:
Frontiers in Pharmacology|July 29, 2016
The Development and Validation of a Generic Instrument, QoDoS, for Assessing the Quality of Decision MakingRonan Donelan, Stuart Walker, Sam Salek
Haematologica|July 2, 2016
Patient-centered research and practice in the era of genomics: a novel approachSam Salek, Esther Oliva, Tatyana Ionova
Pharmacoepidemiology and Drug Safety|January 29, 2015
Factors influencing quality decision-making: regulatory and pharmaceutical industry perspectivesRonan Donelan, Stuart Walker, Sam Salek
European Journal of Haematology|December 18, 2018
Haematological malignancy: Are we measuring what is important to patients? A systematic review of quality-of-life instrumentsPushpendra Goswami, Yasmin Khatib, Sam Salek
Pharmacoepidemiology and Drug Safety|June 5, 2007
A quantitative approach to benefit-risk assessment of medicines - part 1: the development of a new model using multi-criteria decision analysisFilip Mussen, Sam Salek, Stuart Walker
Frontiers in Pharmacology|August 26, 2021
Comparison of BRICS-TM Countries' Biosimilar Regulatory Frameworks With Australia, Canada and Switzerland: Benchmarking Best PracticesHasumati Rahalkar, Alan Sheppard, Sam Salek
Expert Review of Clinical Pharmacology|January 26, 2022
Biosimilar development and review process in the BRICS-TM countries: Proposal for a standardized model to improve regulatory performanceHasumati Rahalkar, Alan Sheppard, Sam Salek
Pharmacoeconomics|February 1, 2006
Incorporating carer effects into economic evaluationSimon Dixon, Mel Walker, Sam Salek
Haematologica|June 5, 2013
Patients' needs in hematology: whose perspectives?Sam Salek, Tatyana Ionova, Esther Oliva, et al.
Frontiers in Pharmacology|July 1, 2015
A practical approach to communicating benefit-risk decisions of medicines to stakeholdersJames Leong, Stuart Walker, Sam Salek
Pageof 15

Showing results (1-10 of 141) with videos related to

Sort By:
Pageof 15
Frontiers in Pharmacology|July 29, 2016
The Development and Validation of a Generic Instrument, QoDoS, for Assessing the Quality of Decision MakingRonan Donelan, Stuart Walker, Sam Salek
Haematologica|July 2, 2016
Patient-centered research and practice in the era of genomics: a novel approachSam Salek, Esther Oliva, Tatyana Ionova
Pharmacoepidemiology and Drug Safety|January 29, 2015
Factors influencing quality decision-making: regulatory and pharmaceutical industry perspectivesRonan Donelan, Stuart Walker, Sam Salek
European Journal of Haematology|December 18, 2018
Haematological malignancy: Are we measuring what is important to patients? A systematic review of quality-of-life instrumentsPushpendra Goswami, Yasmin Khatib, Sam Salek
Pharmacoepidemiology and Drug Safety|June 5, 2007
A quantitative approach to benefit-risk assessment of medicines - part 1: the development of a new model using multi-criteria decision analysisFilip Mussen, Sam Salek, Stuart Walker
Frontiers in Pharmacology|August 26, 2021
Comparison of BRICS-TM Countries' Biosimilar Regulatory Frameworks With Australia, Canada and Switzerland: Benchmarking Best PracticesHasumati Rahalkar, Alan Sheppard, Sam Salek
Expert Review of Clinical Pharmacology|January 26, 2022
Biosimilar development and review process in the BRICS-TM countries: Proposal for a standardized model to improve regulatory performanceHasumati Rahalkar, Alan Sheppard, Sam Salek
Pharmacoeconomics|February 1, 2006
Incorporating carer effects into economic evaluationSimon Dixon, Mel Walker, Sam Salek
Haematologica|June 5, 2013
Patients' needs in hematology: whose perspectives?Sam Salek, Tatyana Ionova, Esther Oliva, et al.
Frontiers in Pharmacology|July 1, 2015
A practical approach to communicating benefit-risk decisions of medicines to stakeholdersJames Leong, Stuart Walker, Sam Salek
Pageof 15